The CXCR3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions

Journal of Investigative Dermatology

Volumn 113, Issue 4, 1999, Pages 574-578

  Flier, Jacoba ^a   Boorsma, Dick M ^a   Bruynzeel, Derk P ^a   Van Beck, Peter J ^a   Stoof, Tom J ^a   Scheper, Rik J ^a   Willemze, Rein ^a   Tensen, Cornelis P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Allergic contact dermatitis; In situ hybridization; Irritant contact dermatitis

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA;

ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; IRRITANT DERMATITIS; KERATINOCYTE; PATCH TEST; PRIORITY JOURNAL; SKIN ALLERGY;

EID: 0032835769     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00730.x     Document Type: Article

References (33)

1. Beljaards RC, Van Beck P, Nieboer C, Stoof TJ, Boorsma DM: The expression of interleukin-8 receptor in untreated and treated psoriasis. Arch Dermatol Res 289:440-443, 1997
2. Berardesca E: What's new in irritant dermatitis. Clin Dermatol 15:561-563, 1997
3. Boorsma DM, de Haan P, Willemze R, Stoof TJ: Human growth factor (huGRO), interleukin-8 (IL-8) and interferon-gamma-inducible protein (gamma-IP-10) gene expression in cultured normal human keratinocytes. Arch Dermatol Res 286:471-475, 1994
4. Boorsma DM, Flier J, Sampat S, et al: Chemokine IP-10 expression in cultured human keratinocytcs. Arch Dermatol Res 290:335-341, 1998
5. Brasch J, Burgard J, Sterry W: Common pathways in allergic and irritant contact dermatitis. J Invest Dermatol 98:166-170, 1992
6. Bruynzeel DP, Andersen KE, Camarasa JG, Lachapelle JM, Menne T, White IR: The European standard series. European Environmental and Contact Dermatitis Research Group (EECDRG). Contact Dermatitis 33:145-148, 1995
7. Cavani A, Mei D, Guerra E, et al: Patients with allergic contact dermatitis to nickel and nonallergic individuals display different nickel-specific T cell responses. Evidence for the presence of effector CD8+ and regulatory CD4+ T cells. J Invest Dermatol 111:621-628, 1998
8. Chuntharapai A, Lee J, Hébert CA, Kim KJ: Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J Immunol 153:5682-5688, 1994
9. Cole K, Strick CA, Paradis TJ, et al: Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 187:2009-2021, 1998
10. Enk AH, Katz SI: Early molocular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 89:1398-1402, 1992
11. Farber JM; HuMig: a new human member of the chemokine family of cytokines. Biochem Biophys Res Commun 15:223-230, 1993
12. Garioch JJ, MacKie RM, Campbell I, Forsyth A: Keratinocyte expression of intercellular adhesion molecule I (ICAM-1) correlated with infiltration of lymphocyte function associated antigen 1 (LFA-1) positive cells in evolving allergic contact dermatitis reactions. Histopathology 19:351-354, 1991
13. Gawkrodger DJ, Carr MM, McVittie E, Guy K, Hunter JAA: Keratinocyte expression of MHC class II antigens in allergic sensitization and challenge reactions and in irritant contact dermatitis. J Invest Dermatol 88:11-16, 1987
14. Goebeler M, Toksoy A, Spandau U, Engelhardt E, Bröcker E-B, Gillitzer R: The CXC chemokine Mig is highly expressed in the papillae of psoriatic lesions. J Pathol 184:89-95, 1998
15. Gottlieb AB, Luster AD, Posnett DN, Carter DM: Detection of a gamma interferon-induced protein IP 10 in psoriatic plaques. J Exp Med 168:941-948, 1988
16. Griffiths CEN, Voorhees JJ, Nickoloff BJ: Characterization of intercellular adhesion molecule 1 and HLA DR expression in normal and inflamed skin: Modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol 20:617-629, 1989
17. Hébert CA, Baker JB: Interleukin-8: a review. Cancer Invest 11:743-501, 1993
18. Hoefakker S, Caubo M, van't Erve EHM, et al: In vivo cytokine profiles in allergic and irritant contact dermatitis. Contact Dermatitis 33:258-266, 1995
19. Jacobs KA, Collins-Racie LA, Colbert M, et al. A genetic selection for isolating cDNAs encoding secreted proteins. Gene 198:289-296, 1997
20. Kaplan G, Luster AD, Hancock G, Cohn ZA: The expression of a γ interferon induced protein (IP-10) in delayed immune responses in human skin. J Exp Med 166:1098-1108, 1987
21. Lange Vejlsgaard GL, Ralfkiaer E, Avnstorp C, Czajkowski M, Martin SD, Rothlein R: Kinetics and characterization of intercellular adhesion molecule-1 (ICAM-1) expression on keratinocytes in various inflammatory skin lesions and malignant cutaneous lymphomas. J Am Acad Dermatol 20:782-790, 1989
22. Loetscher M, Gerber B, Loetscher P, et al: Chemokine receptor specific for IP-10 and Mig: structure, function, and expression in activated T lymphocytes. J Exp Med 184:963-909, 1996
23. Luster AD, Unkeless JC, Ravetch JV: Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315:672-676, 1985
24. Qin S, Rottman JB, Myers P, et al: The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101:746-754, 1998
25. Rani MRS, Foster GR, Leung S, Leaman D, Stark GR, Ransoboff RM: Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha. J Biol Chem 271:22878-22884, 1996
26. Scheynius A, Fischer T: Phenotypic difference between allergic and irritant patch test reactions in man. Contact Dermatitis 14:297-302, 1986
27. Scheynius A, Fischer T, Forsum U, Klareskog L: Phenotypic characterization in situ of inflammatory cells in allergic and irritant contact dermatitis in man. Clin Exp Immunol 55:81-90, 1984
28. Spandau U, Toksoy A, Goebeler M, Brǒcker E-B, Gillitzer R: Mig is a dominant lymphocyte attractant chemokine in lichen planus lesions. J Invest Dermatol 111:1003-1009, 1998
29. Tensen CP, Vermeer MH, van der Stoop PM, van Beek PJ, Scheper RJ, Boorsma DM, Willemze R: Epidermal interferon-(inducible protein-10 (IP-10) and monokine induced by (-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas. J Invest Dermatol 111:222-226, 1998
30. Tensen CP, Flier J, van der Raaij-Helmer EMH, et al: Human IP-9: a keratinocyte derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). J Invest Dermatol 112:716-722, 1999a
31. Tensen CP, Flier J, Rampersad SS, Sampat Sardjoepersad SS, Scheper RJ, Boorsma DM, Willemze R: Genomic organization, sequence and transcriptional regulation of the human CXCL 11 gene. Biochem. Biophys Acta 1446:167-172, 1999b
32. Willis CM, Young E, Brandon DR, Wilkinson JD: Immunopathological and ultrastructural findings in human allergic and irritant contact dermatitis. Br J Dermatol 115:305-316, 1986
33. Willis CM, Stephens CJM, Wilkinson JD; Selective expression of immuno-associated surface antigens by keratinocytes in irritant contact dermatitis. J Invest Dermatol 96:505-511, 1991